Generation of a New Congenic Mouse Strain with Enhanced Chymase Expression in Mast Cells

Por Jin, Xi, Zhao, Wanke, Shi, Kaiyao, Ho, Wanting T., Zhao, Zhizhuang J.
Publicado em 2013

Characterization of a Highly Effective Protein Substrate for Analysis of JAK2(V617F) Activity

Por Li, Zhe, Xing, Shu, Wang, Shaofeng, Ho, Wanting Tina, Zhao, Zhizhuang Joe
Publicado em 2007

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines

Por Zhao, Wanke, Du, Yanhong, Ho, Wanting Tina, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2012

Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line

Por Zhao, Wanke, Zou, Kang, Farasyn, Taleah, Ho, Wanting Tina, Zhao, Zhizhuang Joe
Publicado em 2014

Identification of a variant form of tyrosine phosphatase LYP

Por Wang, Shaofeng, Dong, Hongbo, Han, Jiayu, Ho, Wanting T, Fu, Xueqi, Zhao, Zhizhuang J
Publicado em 2010

Tea Contains Potent Inhibitors of Tyrosine Phosphatase PTP1B

Por Ma, Junfeng, Li, Zhe, Xing, Shu, Ho, Wanting Tina, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2011

Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice

Por Shi, Kaiyao, Zhao, Wanke, Chen, Yun, Ho, Wanting Tina, Yang, Ping, Zhao, Zhizhuang Joe
Publicado em 2014

Characterization and Functional Studies of a FYVE Domain-Containing Phosphatase in C. elegans

Por Ma, Junfeng, Zeng, Fenghua, Ho, Wanting Tina, Teng, Lirong, Li, Qingshan, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2008

Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity

Por Chen, Yun, Guo, Yao, Han, Jiayu, Ho, Wanting Tina, Li, Shibo, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2012

Relevance of JAK2V617F positivity to hematological diseases - survey of samples from a clinical genetics laboratory

Por Zhao, Wanming, Gao, Rufei, Lee, Jiyun, Xing, Shu, Ho, Wanting T, Fu, Xueqi, Li, Shibo, Zhao, Zhizhuang J
Publicado em 2011

Erlotinib Effectively Inhibits JAK2(V617F) Activity and Polycythemia Vera Cell Growth

Por Li, Zhe, Xu, Mingjiang, Xing, Shu, Ho, Wanting Tina, Ishii, Takefumi, Li, Qingshan, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2006

Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia

Por Chen, Yun, Pan, Yihang, Guo, Yao, Zhao, Wanke, Ho, Wanting Tina, Wang, Jianlong, Xu, Mingjiang, Yang, Feng-Chun, Zhao, Zhizhuang Joe
Publicado no Stem Cell Investig (2017)

Efficacy of ALK5 inhibition in myelofibrosis

Por Yue, Lanzhu, Bartenstein, Matthias, Zhao, Wanke, Ho, Wanting Tina, Han, Ying, Murdun, Cem, Mailloux, Adam W., Zhang, Ling, Wang, Xuefeng, Budhathoki, Anjali, Pradhan, Kith, Rapaport, Franck, Wang, Huaquan, Shao, Zonghong, Ren, Xiubao, Steidl, Ulrich, Levine, Ross L., Zhao, Zhizhuang Joe, Verma, Amit, Epling-Burnette, Pearlie K.
Publicado no JCI Insight (2017)

Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

Por Bastarache, Lisa, Hughey, Jacob J., Hebbring, Scott, Marlo, Joy, Zhao, Wanke, Ho, Wanting T., Van Driest, Sara L., McGregor, Tracy L., Mosley, Jonathan D., Wells, Quinn S., Temple, Michael, Ramirez, Andrea H., Carroll, Robert, Osterman, Travis, Edwards, Todd, Ruderfer, Douglas, Velez Edwards, Digna R., Hamid, Rizwan, Cogan, Joy, Glazer, Andrew, Wei, Wei-Qi, Feng, QiPing, Brilliant, Murray, Zhao, Zhizhuang J., Cox, Nancy J., Roden, Dan M., Denny, Joshua C.
Publicado no Science (2018)